Neuroprotective effects of liraglutide for stroke model of rats

Kenichiro Sato, Masahiro Kameda, Takao Yasuhara, Takashi Agari, Tanefumi Baba, Feifei Wang, Aiko Shinko, Takaaki Wakamori, Atsuhiko Toyoshima, Hayato Takeuchi, Tatsuya Sasaki, Susumu Sasada, Akihiko Kondo, Cesario V. Borlongan, Mitsunori Matsumae, Isao Date

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

The number of diabetes mellitus (DM) patients is increasing, and stroke is deeply associated with DM. Recently, neuroprotective effects of glucagon-like peptide-1 (GLP-1) are reported. In this study, we explored whether liraglutide, a GLP-1 analogue exerts therapeutic effects on a rat stroke model. Wistar rats received occlusion of the middle cerebral artery for 90 min. At one hour after reperfusion, liraglutide or saline was administered intraperitoneally. Modified Bederson's test was performed at 1 and 24 h and, subsequently, rats were euthanized for histological investigation. Peripheral blood was obtained for measurement of blood glucose level and evaluation of oxidative stress. Brain tissues were collected to evaluate the level of vascular endothelial growth factor (VEGF). The behavioral scores of liraglutide-treated rats were significantly better than those of control rats. Infarct volumes of liraglutide-treated rats at were reduced, compared with those of control rats. The level of derivatives of reactive oxygen metabolite was lower in liraglutide-treated rats. VEGF level of liraglutide-treated rats in the cortex, but not in the striatum significantly increased, compared to that of control rats. In conclusion, this is the first study to demonstrate neuroprotective effects of liraglutide on cerebral ischemia through anti-oxidative effects and VEGF upregulation.

Original languageEnglish
Pages (from-to)21513-21524
Number of pages12
JournalInternational Journal of Molecular Sciences
Volume14
Issue number11
DOIs
Publication statusPublished - Oct 30 2013

Fingerprint

Neuroprotective Agents
strokes
rats
Rats
Stroke
Rat control
Vascular Endothelial Growth Factor A
Glucagon-Like Peptide 1
Medical problems
diabetes mellitus
Peptides
Blood
Diabetes Mellitus
blood
peptides
Oxidative stress
Metabolites
Liraglutide
ischemia
Glucose

Keywords

  • Cerebral ischemia
  • Diabetes mellitus
  • Glucagon-like peptide-1
  • Liraglutide
  • Oxidative stress
  • Stroke
  • VEGF

ASJC Scopus subject areas

  • Computer Science Applications
  • Molecular Biology
  • Catalysis
  • Inorganic Chemistry
  • Spectroscopy
  • Organic Chemistry
  • Physical and Theoretical Chemistry

Cite this

Neuroprotective effects of liraglutide for stroke model of rats. / Sato, Kenichiro; Kameda, Masahiro; Yasuhara, Takao; Agari, Takashi; Baba, Tanefumi; Wang, Feifei; Shinko, Aiko; Wakamori, Takaaki; Toyoshima, Atsuhiko; Takeuchi, Hayato; Sasaki, Tatsuya; Sasada, Susumu; Kondo, Akihiko; Borlongan, Cesario V.; Matsumae, Mitsunori; Date, Isao.

In: International Journal of Molecular Sciences, Vol. 14, No. 11, 30.10.2013, p. 21513-21524.

Research output: Contribution to journalArticle

Sato, K, Kameda, M, Yasuhara, T, Agari, T, Baba, T, Wang, F, Shinko, A, Wakamori, T, Toyoshima, A, Takeuchi, H, Sasaki, T, Sasada, S, Kondo, A, Borlongan, CV, Matsumae, M & Date, I 2013, 'Neuroprotective effects of liraglutide for stroke model of rats', International Journal of Molecular Sciences, vol. 14, no. 11, pp. 21513-21524. https://doi.org/10.3390/ijms141121513
Sato, Kenichiro ; Kameda, Masahiro ; Yasuhara, Takao ; Agari, Takashi ; Baba, Tanefumi ; Wang, Feifei ; Shinko, Aiko ; Wakamori, Takaaki ; Toyoshima, Atsuhiko ; Takeuchi, Hayato ; Sasaki, Tatsuya ; Sasada, Susumu ; Kondo, Akihiko ; Borlongan, Cesario V. ; Matsumae, Mitsunori ; Date, Isao. / Neuroprotective effects of liraglutide for stroke model of rats. In: International Journal of Molecular Sciences. 2013 ; Vol. 14, No. 11. pp. 21513-21524.
@article{f79e163b51f040e28b7196199365b49d,
title = "Neuroprotective effects of liraglutide for stroke model of rats",
abstract = "The number of diabetes mellitus (DM) patients is increasing, and stroke is deeply associated with DM. Recently, neuroprotective effects of glucagon-like peptide-1 (GLP-1) are reported. In this study, we explored whether liraglutide, a GLP-1 analogue exerts therapeutic effects on a rat stroke model. Wistar rats received occlusion of the middle cerebral artery for 90 min. At one hour after reperfusion, liraglutide or saline was administered intraperitoneally. Modified Bederson's test was performed at 1 and 24 h and, subsequently, rats were euthanized for histological investigation. Peripheral blood was obtained for measurement of blood glucose level and evaluation of oxidative stress. Brain tissues were collected to evaluate the level of vascular endothelial growth factor (VEGF). The behavioral scores of liraglutide-treated rats were significantly better than those of control rats. Infarct volumes of liraglutide-treated rats at were reduced, compared with those of control rats. The level of derivatives of reactive oxygen metabolite was lower in liraglutide-treated rats. VEGF level of liraglutide-treated rats in the cortex, but not in the striatum significantly increased, compared to that of control rats. In conclusion, this is the first study to demonstrate neuroprotective effects of liraglutide on cerebral ischemia through anti-oxidative effects and VEGF upregulation.",
keywords = "Cerebral ischemia, Diabetes mellitus, Glucagon-like peptide-1, Liraglutide, Oxidative stress, Stroke, VEGF",
author = "Kenichiro Sato and Masahiro Kameda and Takao Yasuhara and Takashi Agari and Tanefumi Baba and Feifei Wang and Aiko Shinko and Takaaki Wakamori and Atsuhiko Toyoshima and Hayato Takeuchi and Tatsuya Sasaki and Susumu Sasada and Akihiko Kondo and Borlongan, {Cesario V.} and Mitsunori Matsumae and Isao Date",
year = "2013",
month = "10",
day = "30",
doi = "10.3390/ijms141121513",
language = "English",
volume = "14",
pages = "21513--21524",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "11",

}

TY - JOUR

T1 - Neuroprotective effects of liraglutide for stroke model of rats

AU - Sato, Kenichiro

AU - Kameda, Masahiro

AU - Yasuhara, Takao

AU - Agari, Takashi

AU - Baba, Tanefumi

AU - Wang, Feifei

AU - Shinko, Aiko

AU - Wakamori, Takaaki

AU - Toyoshima, Atsuhiko

AU - Takeuchi, Hayato

AU - Sasaki, Tatsuya

AU - Sasada, Susumu

AU - Kondo, Akihiko

AU - Borlongan, Cesario V.

AU - Matsumae, Mitsunori

AU - Date, Isao

PY - 2013/10/30

Y1 - 2013/10/30

N2 - The number of diabetes mellitus (DM) patients is increasing, and stroke is deeply associated with DM. Recently, neuroprotective effects of glucagon-like peptide-1 (GLP-1) are reported. In this study, we explored whether liraglutide, a GLP-1 analogue exerts therapeutic effects on a rat stroke model. Wistar rats received occlusion of the middle cerebral artery for 90 min. At one hour after reperfusion, liraglutide or saline was administered intraperitoneally. Modified Bederson's test was performed at 1 and 24 h and, subsequently, rats were euthanized for histological investigation. Peripheral blood was obtained for measurement of blood glucose level and evaluation of oxidative stress. Brain tissues were collected to evaluate the level of vascular endothelial growth factor (VEGF). The behavioral scores of liraglutide-treated rats were significantly better than those of control rats. Infarct volumes of liraglutide-treated rats at were reduced, compared with those of control rats. The level of derivatives of reactive oxygen metabolite was lower in liraglutide-treated rats. VEGF level of liraglutide-treated rats in the cortex, but not in the striatum significantly increased, compared to that of control rats. In conclusion, this is the first study to demonstrate neuroprotective effects of liraglutide on cerebral ischemia through anti-oxidative effects and VEGF upregulation.

AB - The number of diabetes mellitus (DM) patients is increasing, and stroke is deeply associated with DM. Recently, neuroprotective effects of glucagon-like peptide-1 (GLP-1) are reported. In this study, we explored whether liraglutide, a GLP-1 analogue exerts therapeutic effects on a rat stroke model. Wistar rats received occlusion of the middle cerebral artery for 90 min. At one hour after reperfusion, liraglutide or saline was administered intraperitoneally. Modified Bederson's test was performed at 1 and 24 h and, subsequently, rats were euthanized for histological investigation. Peripheral blood was obtained for measurement of blood glucose level and evaluation of oxidative stress. Brain tissues were collected to evaluate the level of vascular endothelial growth factor (VEGF). The behavioral scores of liraglutide-treated rats were significantly better than those of control rats. Infarct volumes of liraglutide-treated rats at were reduced, compared with those of control rats. The level of derivatives of reactive oxygen metabolite was lower in liraglutide-treated rats. VEGF level of liraglutide-treated rats in the cortex, but not in the striatum significantly increased, compared to that of control rats. In conclusion, this is the first study to demonstrate neuroprotective effects of liraglutide on cerebral ischemia through anti-oxidative effects and VEGF upregulation.

KW - Cerebral ischemia

KW - Diabetes mellitus

KW - Glucagon-like peptide-1

KW - Liraglutide

KW - Oxidative stress

KW - Stroke

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=84886866578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886866578&partnerID=8YFLogxK

U2 - 10.3390/ijms141121513

DO - 10.3390/ijms141121513

M3 - Article

C2 - 24177570

AN - SCOPUS:84886866578

VL - 14

SP - 21513

EP - 21524

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 11

ER -